Charles River (CRL) signs a lentiviral vector contract development and manufacturing organization agreement with Gates Institute to help develop...

MONDAY, June 24, 2024 -- Automated quantitative tests for NT-proBNP and interleukin 1 receptor-like 1 (IL-1 RL1) can identify high-risk congenital...

National Information Technology Development Agency (NITDA) is set to collaborate with the Africa Centre of Excellence for Population Health and Policy...

Why organizations of every size and industry should explore their cyber insurance options as a crucial component of their risk mitigation strategies...

Why organizations of every size and industry should explore their cyber insurance options as a crucial component of their risk mitigation strategies...

Researchers on the “Current and Future Risks of Urban and Rural Flooding in West Africa” (FURIFLOOD) project are developing a guidebook on...

Fuel cell system specialist cellcentric announces its innovative NextGen fuel cell system tailored for long-haul trucks also in North America. As a...

GBP34000 - GBP40000 per year: Immunocore: Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose...

GBP75000 - GBP90000 per year: Immunocore: Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose...

On June 26, 2024, the Food and Drug Administration granted accelerated approval to epcoritamab-bysp, a bispecific CD20-directed CD3 T-cell engager,...